PE20050919A1 - Agente endoparasiticida para administracion topica - Google Patents

Agente endoparasiticida para administracion topica

Info

Publication number
PE20050919A1
PE20050919A1 PE2004001220A PE2004001220A PE20050919A1 PE 20050919 A1 PE20050919 A1 PE 20050919A1 PE 2004001220 A PE2004001220 A PE 2004001220A PE 2004001220 A PE2004001220 A PE 2004001220A PE 20050919 A1 PE20050919 A1 PE 20050919A1
Authority
PE
Peru
Prior art keywords
agent
acts
endoparasiticided
topical administration
terpene
Prior art date
Application number
PE2004001220A
Other languages
English (en)
Spanish (es)
Inventor
Venkata-Rangarao Kanikanti
Thomas Bach
Michael Traubel
Hans-Jurgen Hamann
Gertraut Altreuther
Original Assignee
Bayer Animal Health Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Animal Health Gmbh filed Critical Bayer Animal Health Gmbh
Publication of PE20050919A1 publication Critical patent/PE20050919A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A61K9/0017—Non-human animal skin, e.g. pour-on, spot-on
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/15—Depsipeptides; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Dermatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Communicable Diseases (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
PE2004001220A 2003-12-13 2004-12-10 Agente endoparasiticida para administracion topica PE20050919A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE10358525A DE10358525A1 (de) 2003-12-13 2003-12-13 Endoparasitizide Mittel zur topischen Applikation

Publications (1)

Publication Number Publication Date
PE20050919A1 true PE20050919A1 (es) 2005-12-16

Family

ID=34638681

Family Applications (1)

Application Number Title Priority Date Filing Date
PE2004001220A PE20050919A1 (es) 2003-12-13 2004-12-10 Agente endoparasiticida para administracion topica

Country Status (31)

Country Link
US (1) US7763583B2 (https=)
EP (1) EP1694291B1 (https=)
JP (1) JP4842141B2 (https=)
KR (1) KR101272139B1 (https=)
CN (1) CN1893919B (https=)
AR (1) AR046878A1 (https=)
AT (1) ATE447940T1 (https=)
AU (1) AU2004296537B2 (https=)
BR (1) BRPI0417578B1 (https=)
CA (1) CA2548897C (https=)
CR (1) CR8428A (https=)
DE (2) DE10358525A1 (https=)
DK (1) DK1694291T3 (https=)
ES (1) ES2334920T3 (https=)
GT (1) GT200400264A (https=)
HR (1) HRP20100056T1 (https=)
IL (1) IL176151A (https=)
MX (1) MXPA06006594A (https=)
MY (1) MY142044A (https=)
NO (1) NO20063171L (https=)
NZ (1) NZ547837A (https=)
PE (1) PE20050919A1 (https=)
PL (1) PL1694291T3 (https=)
PT (1) PT1694291E (https=)
RU (1) RU2401108C2 (https=)
SI (1) SI1694291T1 (https=)
TW (1) TWI341202B (https=)
UA (1) UA85574C2 (https=)
UY (1) UY28662A1 (https=)
WO (1) WO2005055973A2 (https=)
ZA (1) ZA200604744B (https=)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070148228A1 (en) * 1999-02-22 2007-06-28 Merrion Research I Limited Solid oral dosage form containing an enhancer
US7658938B2 (en) 1999-02-22 2010-02-09 Merrion Reasearch III Limited Solid oral dosage form containing an enhancer
US8119159B2 (en) 1999-02-22 2012-02-21 Merrion Research Iii Limited Solid oral dosage form containing an enhancer
DE102004055316A1 (de) * 2004-11-16 2006-05-18 Bayer Healthcare Ag Verhinderung vertikaler Endoparasiten-Infektionen
DE102005011779A1 (de) * 2005-03-11 2006-09-14 Bayer Healthcare Ag Endoparasitizide Mittel
BRPI0710503A2 (pt) 2006-04-07 2011-08-16 Merrion Res Iii Ltd uso de uma composição farmacêutica, composição farmacêutica, e, forma de dosagem oral
JP2009539862A (ja) * 2006-06-09 2009-11-19 メリオン リサーチ Ｉｉｉ リミテッド 強化剤を含む固体経口投与剤形
PE20081406A1 (es) * 2006-12-20 2008-10-17 Schering Plough Ltd Composiciones farmaceuticas de flunixina
RU2517135C2 (ru) * 2008-05-07 2014-05-27 Меррион Рисерч Iii Лимитед Композиции пептидов и способы их получения
DE102008022520A1 (de) * 2008-05-07 2009-11-12 Bayer Animal Health Gmbh Feste Arzneimittelformulierung mit verzögerter Freisetzung
WO2010042395A1 (en) * 2008-10-08 2010-04-15 Wyeth Llc Benzimidazole anthelmintic compositions
CA2751854A1 (en) * 2009-02-25 2010-09-02 Merrion Research Iii Limited Composition and drug delivery of bisphosphonates
DE102009012423A1 (de) 2009-03-10 2010-09-16 Bayer Animal Health Gmbh Zubereitung auf Ölbasis
BRPI1009199A2 (pt) 2009-03-17 2016-03-08 Concert Pharmaceuticals Inc compostos de pirazinoisoquinolina
WO2011013003A2 (en) 2009-07-31 2011-02-03 Shin Nippon Biomedical Laboratories, Ltd. Intranasal granisetron and nasal applicator
US20110182985A1 (en) * 2010-01-28 2011-07-28 Coughlan David C Solid Pharmaceutical Composition with Enhancers and Methods of Preparing thereof
US9089484B2 (en) 2010-03-26 2015-07-28 Merrion Research Iii Limited Pharmaceutical compositions of selective factor Xa inhibitors for oral administration
KR20140026354A (ko) 2011-01-07 2014-03-05 메리온 리서치 Ⅲ 리미티드 경구 투여용 철의 제약 조성물
US8680054B2 (en) * 2011-04-20 2014-03-25 Novartis Ag Suspension type topical formulations comprising cyclic depsipeptide
CN102283843A (zh) * 2011-06-29 2011-12-21 梁晓天 一种吡喹酮外用制剂及其制备方法和应用
CN104023710A (zh) * 2011-12-21 2014-09-03 拜耳知识产权有限责任公司 包含无定形艾默德斯的制剂
BR112015014266B1 (pt) * 2012-12-18 2021-01-26 Donaghys Limited formulação parasiticida transdermal na forma de uma solução
KR20160115993A (ko) * 2014-02-14 2016-10-06 디에스엠 아이피 어셋츠 비.브이. 주혈흡충병의 예방 및/또는 치료를 위한 조성물 및 방법
JP7211704B2 (ja) 2015-01-29 2023-01-24 ノヴォ ノルディスク アー／エス Ｇｌｐ－１アゴニスト及び腸溶コーティングを含む錠剤
CN107835818B (zh) 2015-05-20 2022-04-29 勃林格殷格翰动物保健美国公司 驱虫缩酚酸肽化合物
BR112018013369A2 (pt) 2015-12-28 2019-02-19 Merial, Inc. compostos depsipeptídicos anti-helmínticos
EP3541789A1 (en) 2016-11-16 2019-09-25 Boehringer Ingelheim Animal Health USA Inc. Anthelmintic depsipeptide compounds
EP3480195A1 (en) 2017-11-07 2019-05-08 Bayer Animal Health GmbH Method for the synthesis of cyclic depsipeptides
IL274283B2 (en) 2017-11-07 2025-03-01 Bayer Animal Health Gmbh Method for the synthesis of cyclic depsipeptides
CN111346046B (zh) * 2020-03-06 2021-07-09 安徽农业大学 一种含莫西菌素注射用缓释凝胶制剂及制备方法

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US281292A (en) * 1883-07-17 onslow
DE2362539C2 (de) * 1973-12-17 1986-05-07 Merck Patent Gmbh, 6100 Darmstadt 2-Acyl-4-oxo-1,2,3,6,7,11b-hexahydro-4H-pyrazino[2,1-a]isochinoline, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
DE3619030A1 (de) * 1986-06-06 1987-12-10 Bayer Ag Topisch anwendbare zubereitungen
DE3634755A1 (de) * 1986-10-11 1988-04-14 Bayer Ag Dermale behandlung von wurmerkrankungen der katze mit praziquantel
NO176766C (no) 1989-02-07 1995-05-24 Meiji Seika Kaisha Fremgangsmåte for fremstilling av en forbindelse med anthelmintaktivitet
US5874479A (en) * 1991-03-01 1999-02-23 Warner-Lambert Company Therapeutic permeation enhanced-wound healing compositions and methods for preparing and using same
DE4317458A1 (de) 1992-06-11 1993-12-16 Bayer Ag Verwendung von cyclischen Depsipeptiden mit 18 Ringatomen zur Bekämpfung von Endoparasiten, neue cyclische Depsipeptide mit 18 Ringatomen und Verfahren zu ihrer Herstellung
DE4317457A1 (de) 1993-05-26 1994-12-01 Bayer Ag Octacyclodepsipeptide mit endoparasitizider Wirkung
DE4317432A1 (de) 1993-05-26 1994-12-01 Bayer Ag Octacyclodepsipeptide mit endoparasitizider Wirkung
DE4400464A1 (de) * 1994-01-11 1995-07-13 Bayer Ag Endoparasitizide Mittel
NZ260018A (en) 1994-03-03 1995-10-26 Bomac Lab Ltd Benzimidazole compositions and anthelmintic compositions
DE19520275A1 (de) * 1995-06-02 1996-12-05 Bayer Ag Endoparasitizide Mittel
US5780487A (en) 1995-08-07 1998-07-14 Amer Moh Samir S-2'- 2-(1-methyl-2-piperidyl) ethyl! cinnamanilide
DE19601263A1 (de) 1996-01-16 1997-07-17 Bayer Ag Anthelmintische Paste
DE19628776A1 (de) 1996-07-17 1998-01-22 Bayer Ag Oral applizierbare Granulate von Hexahydropyrazinderivaten
US5837289A (en) * 1996-07-23 1998-11-17 Grasela; John C. Transdermal delivery of medications using a combination of penetration enhancers
DE19921887A1 (de) * 1999-05-12 2000-11-16 Bayer Ag Endoparasitizide Mittel
DE19941024A1 (de) 1999-08-28 2001-03-01 Hartmut Klocke Wirkstoffpräparat für tierärztliche Applikation und Verfahren zu seiner Herstellung
KR20020058023A (ko) * 1999-11-18 2002-07-12 한스 루돌프 하우스, 헨리테 브룬너, 베아트리체 귄터 살충성 아미노헤테로시클릴아미드 화합물
US6340672B1 (en) * 2000-02-16 2002-01-22 Phoenix Scientific, Inc. Parasiticidal formulation and a method of making this formulation
DE10008128A1 (de) 2000-02-22 2001-08-23 Bayer Ag Endoparasitizide Mittel
ES2258062T3 (es) 2000-10-10 2006-08-16 Wyeth Composicion antihelmintica.
NZ526538A (en) * 2000-12-20 2005-12-23 Novartis Ag Anti-endoparasitic amidoacetonitrils
GB0108485D0 (en) 2001-04-04 2001-05-23 Pfizer Ltd Combination therapy
US6893652B2 (en) 2001-08-27 2005-05-17 Wyeth Endoparasiticidal gel composition
BRPI0409185B1 (pt) * 2003-04-04 2018-05-15 Merial, Inc Formulações veterinárias anti-helmínticas tópicas

Also Published As

Publication number Publication date
CN1893919B (zh) 2010-09-29
WO2005055973A2 (de) 2005-06-23
UA85574C2 (uk) 2009-02-10
WO2005055973A3 (de) 2005-08-11
MY142044A (en) 2010-08-30
RU2401108C2 (ru) 2010-10-10
EP1694291A2 (de) 2006-08-30
IL176151A0 (en) 2006-10-05
HK1102915A1 (en) 2007-12-07
ZA200604744B (en) 2007-09-26
PT1694291E (pt) 2010-01-18
BRPI0417578B1 (pt) 2015-12-22
SI1694291T1 (sl) 2010-03-31
CA2548897A1 (en) 2005-06-23
ES2334920T3 (es) 2010-03-17
UY28662A1 (es) 2005-07-29
DK1694291T3 (da) 2010-03-15
BRPI0417578A (pt) 2007-03-20
CN1893919A (zh) 2007-01-10
DE502004010367D1 (de) 2009-12-24
JP4842141B2 (ja) 2011-12-21
AR046878A1 (es) 2005-12-28
AU2004296537B2 (en) 2010-05-13
CA2548897C (en) 2012-04-10
GT200400264A (es) 2005-08-18
HRP20100056T1 (hr) 2010-03-31
MXPA06006594A (es) 2006-08-23
EP1694291B1 (de) 2009-11-11
DE10358525A1 (de) 2005-07-07
CR8428A (es) 2006-11-23
US7763583B2 (en) 2010-07-27
US20070060509A1 (en) 2007-03-15
RU2006124964A (ru) 2008-01-20
KR101272139B1 (ko) 2013-06-10
KR20060103953A (ko) 2006-10-04
JP2007513903A (ja) 2007-05-31
NO20063171L (no) 2006-07-07
AU2004296537A1 (en) 2005-06-23
ATE447940T1 (de) 2009-11-15
NZ547837A (en) 2010-02-26
IL176151A (en) 2013-12-31
TWI341202B (en) 2011-05-01
TW200533384A (en) 2005-10-16
PL1694291T3 (pl) 2010-04-30

Similar Documents

Publication Publication Date Title
PE20050919A1 (es) Agente endoparasiticida para administracion topica
SV2004001556A (es) Preparaciones acidas de insulina con establidad mejorada
GT199900203A (es) Composiciones de celecoxib.
BR0313343A (pt) Uso de uma mistura de agentes permeantes, soluções para aplicação ungueal e periungueal e uso de uma solução para aplicação ungueal e periungueal
AR021539A1 (es) Preparaciones topicas anhidras para la piel
ECSP10010184A (es) Producto de dispersión sólida que contiene un compuesto a base de n-aril-urea
AR040302A1 (es) Dispositivos para la liberacion transdermica de farmacos, que presentan microprotrusiones recubiertas
BR0114628A (pt) Membro de retenção em microprojeção para aplicador de impacto
BR112014000178A2 (pt) composições tópicas
CL2004000566A1 (es) Sistema de liberacion controlada que contiene un componente farmaceuticamente activo, acetato de isobutirato de sacarosa (saib), y como disolvente glicerolformal o isopropilidenglicerol o una mezcla de los mismos.
PE20090605A1 (es) Composiciones de fenilalanina amoniaco-liasa procariotica y metodos del tratamiento del cancer usando composiciones de la misma
AR027510A1 (es) Formulacion
PA8584101A1 (es) Composicion antihelmintica e inyectable mejoradora de crecimiento
CR6844A (es) Emulsiones con esteres de naftalato
AR085989A2 (es) Composiciones endoparasiticidas y proceso para su preparacion
MX2007010881A (es) Composiciones de peroxido de benzoilo y metodos de uso.
CO2021016449A2 (es) Composiciones terapéuticas estables en solventes polares aproticos y métodos de fabricación de las mismas
PA8532001A1 (es) Bifenilcarboxamidas utiles como agentes reductores de lipidos
ATE501710T1 (de) Somatostatin-analog-formulierungen
PE20050923A1 (es) Composicion solida que comprende un sensibilizador de insulina, un secretagogo de insulina y un ester de acidos grasos
PE20040471A1 (es) Formulaciones de liberacion prolongada en forma de suspension
DOP2010000117A (es) Producto de dispersion solida de drogas basadas en n-aril urea
ATE242965T1 (de) Mittel zur viruziden händedesinfektion
PE20051035A1 (es) Hormonas de administracion transdermica que no necesitan potenciadores de penetracion
MX2007006775A (es) Composiciones estables de fenofibrato con esteres de acido graso.

Legal Events

Date Code Title Description
FC Refusal